Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Unknown 15Not yet recruiting 3Completed 2Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Acute Toxic Effects 1

Interventions

Cyclophosphamide 1499Cisplatin 1434Paclitaxel 1339Radiotherapy 1310Carboplatin 1266Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 697Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × lobaplatin × Clear all
NCT03413436 2020-08-28

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

Henan Cancer Hospital

Phase 4 Completed
733 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT03188497 2018-04-10

Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial

Fifth Affiliated Hospital, Sun Yat-Sen University

Phase 1 Completed
17 enrolled

Acute Toxic Effects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡